2019 Cannabis Business Award's
Publication of the Year |
REGISTER FOR TONIGHT'S MEETING
MAY 3, 2023 SPECIAL LEGISLATIVE UPDATE THE "FLORIDA MEDICAL CANNABIS
PHYSICIAN GROUP" (FMCPG) FOR ALL "MEDICAL MARIJUANA DOCTORS"
AND "MMTC DIRECTORS ONLY "
SIGN UP TODAY
TOPICS TO BE DISCUSSED FOLLOW UP ON RECENT DEVELOPMENTS ON 2023 LEGISLATIVE ISSUES FROM OUR APRIL 26TH MEETING WHAT CAN HURT YOUR PRACTICE UPDATE FROM TALLAHASSEE ON TELEHEALTH BILL FOR CANNABIS PATIENTS
PASSED BY THE HOUSE, NOW WAITING ON THE SENATE UPDATE FROM TALLAHASSEE ON THE HEMP BILL PROTECTING YOUR MEDICAL CANNABIS PRACTICE
QUESTIONS FROM PHYSICIANS HOW TO BEST ANSWER YOUR PATIENT QUESTIONS
CLICK HERE TO REGISTER FOR THE MAY 3RD MEETING |
JOIN CANNABIS NEWS FLORIDA AND FLORIDA MEDICAL CANNABIS PHYSICIANS GROUP
AT FMCCE ON JUNE 2 - 4 IN ORLANDO |
ASK ABOUT FLORIDA MEDICAL CANNABIS PHYSICIAN GROUP DISCOUNT
Email me at: charles@cannabisnewsflorida.com phone: 954-605-4785 |
NEWS FROM THE PAST WEEK RELATING TO THE BUSINESS OF CANNABIS IN FLORIDA Click on Company Logo to be Transferred to Web Site |
TRULIEVE ANNOUNCES GEORGIA’S FIRST MEDICAL CANNABIS DISPENSARY
New dispensary in Macon provides first patient access to medical cannabis in the state
TALLAHASSEE, Fla., April 27, 2023 — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the United States, today announced the grand opening of Georgia’s first medical cannabis dispensary in Macon. The new dispensary will be open 10 AM – 7 PM, seven days a week and is located at 3556 Riverside Dr.
Trulieve will host a grand opening celebration on Friday, April 28 at 9:30 AM with a ribbon cutting, food trucks and merchandise giveaways.
The Company will open three more dispensaries this year located at:
Columbus: 4238 Armour Road
Newnan: 1690 E Hwy 34
Pooler: 2002 Pooler Parkway
READ MORE |
Florida 1977. A dirt-poor country boy from Florida’s panhandle orchestrates the largest marijuana smuggling operation in U.S. Department of Justice history.
Using shrimp boats, airboats, old moonshine running routes and tiny North Florida waterways this fella and his crew smuggled more than one and a half million pounds of Colombian marijuana into the sunshine state and pocketed $320 million in the process.
To clean the cash these outlaws obtained the U.S. distribution rights to a well-known French sun care company called “Sun System”. The crew lived life wide open, full throttle and did it publicly. They raced cars at the Indy 500, ran Daytona, and even won Le Mans all under the “Sun System” banner.
This brazen lifestyle caught the FBI’s attention, so the bureau created a satellite office in Panama City Beach specifically to go after this organization. The feds dubbed the investigation “Operation Sunburn”.
The band leader of the Operation Sunburn outlaws was a fella named Bill Cobb, the father of our CEO Brady Cobb. the cannabis business is not only our culture here, it’s literally in our blood.
Naming our company “Sunburn” pays tribute to the outlaws, outliers and trailblazers that paved the way in Florida cannabis culture. Sunburn was created to give America permission to be rebellious, spontaneous, sexy and have fun again, unapologetically. Our crew today, much like Bill Cobb’s crew in the past believes the best way to create that feeling is through quality cannabis and an embrace of the exciting and rock-n-roll, fast life inspired by the late 70’s Southern Americana.
https://www.sunburncannabis.com/stories/operation-sunburn/ |
CURALEAF REPORTS FOURTH QUARTER AND FISCAL YEAR END 2022 RESULTS
Record fiscal year 2022 revenue of $1.34 billion and Adjusted EBITDA(1) of $305 million, representing an increase of 12% and 17% from fiscal 2021, respectively
Fourth quarter 2022 Revenue of $352.5 million, representing an increase of 14% year-over-year, and Adjusted EBITDA(1) of $73 million
Operating cash flow of $46 million and cash on balance sheet of $163 million
NEW YORK, May 1, 2023 — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in cannabis, today reported its financial and operating results for the fourth quarter and year ended December 31, 2022. All financial information is reported in accordance with U.S. generally accepted accounting principles (GAAP) and is provided in U.S. dollars unless otherwise indicated.
Boris Jordan, Executive Chairman of Curaleaf, commented, “2022 was another record year for Curaleaf that further solidified our leadership position in the industry. In the fourth quarter, we delivered sales growth of 14% to $352.5 million , with an adjusted gross margin1 of 47% and adjusted EBITDA margin of 21%. For the year, we grew revenue by 12% to $1.34 billion , with an adjusted gross margin of 50% and adjusted EBITDA margin of 23%. We generated $46 million in operating cash flow and ended the year with $163 million in cash on our balance sheet. We have a strong cash position and will continue to invest in the right opportunities for growth domestically and abroad. I am pleased that we took the necessary actions in Q4 and early Q1 to reduce expenses and streamline the organization, positioning us for years of profitable growth to come.”
READ MORE |
GREEN THUMB INDUSTRIES ANNOUNCES APPOINTMENT OF ETHAN NADELMANN TO BOARD OF DIRECTORS
CHICAGO and VANCOUVER, British Columbia, April 27, 2023 — Green Thumb Industries Inc. (“Green Thumb”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced that Ethan Nadelmann has been appointed to its board of directors. Nadelmann will join the board as an independent director and member of the compensation committee.
Nadelmann brings over 35 years of experience in cannabis policy reform and has a proven track record of transforming state, federal and foreign cannabis and other drug policies through assorted advocacy efforts. He is the founder of both the Drug Policy Alliance, where he served as executive director from 2000 to 2017, and prior to that, The Lindesmith Center, an Open Society Institute project that he directed from 1994 to 2000. Additionally, Nadelmann co-founded the International Harm Reduction Development Program of the Open Society Foundations (“OSF”) and served on its advisory board as well as that of the OSF’s Global Drug Policy Program.
“Ethan’s deep understanding of the cannabis industry and passion for our mission make him a perfect fit for our board,” said Green Thumb Founder, Chairman and Chief Executive Officer Ben Kovler. “His career-long impact of shifting public opinion about cannabis and advancing legalization efforts is inspiring, and we look forward to the contributions he will bring to our team.”
READ MORE |
NEW NAME HOUSE OF PLATINUM CANNABIS |
CANSORTIUM REPORTS FOURTH QUARTER AND FULL YEAR 2022 RESULTS
Q4 Revenue up 28% YoY to $23.5 Million; FY 2022 Revenue up 34% YoY to $87.7 Million –
– FY 2022 Cash from Operations up Significantly to $19.1 Million, Compared to Cash Used of $5.0 Million in FY 2021 –
MIAMI, May 1, 2023 – Cansortium Inc. (CSE: TIUM.U) (OTCQX: CNTMF) (“Cansortium” or the “Company”), a vertically-integrated, multi-state cannabis company operating under the Fluent™ brand, today announced financial and operating results for the fourth quarter and full year ended December 31, 2022. Unless otherwise indicated, all results are presented in U.S. dollars.
“We delivered strong revenue growth and material cash flow generation in 2022 despite a challenging backdrop for the broader cannabis industry, as well as the adverse impact we experienced in Florida from Hurricane Ian,” said CEO Robert Beasley. “Within our home market of Florida, we captured meaningful market share driven in part by our cultivation improvements and new store openings over the course of 2022. In addition, our exit from Michigan last August enabled us to strategically reallocate capital and sharpen focus on our core operations.
READ MORE |
INTERNATIONAL CANNABIS BRAND COOKIES CLOSES EQUITY FINANCING AT HIGHEST VALUATION IN COMPANY HISTORY
Proceeds from the Series A Financing Will Be Used For General Working Capital Purposes, to Repay Existing Indebtedness and to Continue Cookies’ Expansion
April 2023 – SAN FRANCISCO–(BUSINESS WIRE)–International cannabis brand Cookies today announced the closing of its Series A round of financing, the company’s largest equity raise at the highest valuation since it launched in 2012.
“We are thrilled to achieve this major milestone for the company, especially in light of the severe hardships being experienced across the industry”
Entourage Effect Capital led the round, followed by 12/12 Ventures. In conjunction with this milestone, Cookies also announces that Matt Barron, Co-Founder and Managing Partner of 12/12 Ventures, has been appointed to the company’s board of directors.
As Cookies closes this major round of financing, the company forges ahead serving customers in markets across the globe. In 2022, Cookies opened 15 retail stores in 8 new markets including Arkansas, Florida, Missouri, Cookies’ first dispensary in Canada, and Cookies’ first market in Asia: Thailand. This year, Cookies will open an additional 15 retail locations while entering several new markets including Arizona, Illinois, Washington D.C. and Australia.
READ MORE |
NATIONAL AND INTERNATIONAL NEWS |
AMERICAN MEDICAL ASSOCIATION TO ISSUE FIRST NEW CODE FOR PSYCHEDELIC THERAPIES
COMPASS Pathways and MAPS PBC submitted joint application for new code to facilitate access to psychedelic therapy in the US, if approved
LONDON and SAN JOSE, Calif., May 02, 2023 – COMPASS Pathways plc (Nasdaq: CMPS) (COMPASS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, and MAPS Public Benefit Corporation (MAPS PBC), a clinical-stage company dedicated to changing the way mental health conditions are treated, today announced that the American Medical Association (AMA) has approved a Current Procedural Terminology (CPT®) III code for psychedelic therapies. The full details of the code are expected to be released by the AMA in July 2023 and the code will go into effect when it is published on January 1, 2024. Once effective, the CPT code will provide physicians and other qualified healthcare professionals a means to code and seek reimbursement for delivering psychedelic therapies.
The application for the new CPT III code was the result of a collaboration between MAPS PBC and COMPASS Pathways to facilitate reimbursement and ultimately access to psychedelic therapies in the US, if approved by the US Food Drug Administration (FDA). Both companies are working to develop and, subject to FDA approval, commercialize psychedelics as part of a new treatment paradigm for individuals with mental health conditions. COMPASS Pathways is conducting a phase 3 program of investigational COMP360 psilocybin therapy in treatment-resistant depression (TRD), having already published positive results in the New England Journal of Medicine from its phase 2b study of COMP360 in TRD, in the largest study of its kind. MAPS PBC has completed two phase 3 clinical trials evaluating MDMA-assisted therapy as a potential treatment for post-traumatic stress disorder (PTSD), both of which met their pre-specified primary and secondary endpoints. This new code may provide a mechanism by which these new treatments being developed by COMPASS and MAPS PBC could be reimbursed if they are approved by the FDA.
READ MORE |
ENTOURAGE HEALTH REPORTS FISCAL YEAR 2022 FINANCIAL RESULTS AND POSTS $54.5 MILLION IN TOTAL REVENUES
The Company positions its 2023 business outlook to drive profitability and deliver enhanced premium product offerings, paving the way for long-term sustainability
Record net medical revenue of $17.4 million for 2022, representing 16% growth
Entourage secured a 5% share of total sales, ranking them in the fourth spot of national pre-roll sales in 2022
Upsized credit facility with LiUNA Pension Fund Central and Eastern Canada (“LPF”) improves liquidity position
TORONTO, May 01, 2023 (GLOBE NEWSWIRE) — Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company“), a Canadian producer and distributor of award-winning cannabis products, announced today its financial results for the fiscal year ended December 31, 2022.
“Attaining success in the cannabis market requires a two-fold approach, which involves producing high-quality products that foster customer loyalty while also implementing sound financial management practices that enable sustainable business growth,” stated George Scorsis, CEO and Executive Chairman. “By adopting an asset-light model, we are focusing on investing in strategic partnerships and executing a strong business plan that prioritizes enhanced efficiency and cost accountability. This approach will enable the Company to focus on its core competencies, establishing a strong brand presence within the constantly evolving cannabis industry.”
READ MORE
|
DELTA 9 AWARDED GROW POD CONTRACT FOR CULTIVATION FACILITY IN ALABAMA WINNIPEG, Manitoba, April 28, 2023 – DELTA 9 CANNABIS INC. (TSX:DN) (OTCQX:DLTNF) (“Delta 9” or the “Company”) is pleased to announce that it has secured a purchase order from a United States based customer (the “Customer”) for up to 8 of its modular Grow Pods for an integrated pre-licensed cultivation and processing facility in Alabama. The Customer has also entered into a Strategic Cooperation Agreement with the Company whereby Delta 9 will provide services relating to the development of the Customer’s cannabis production facility, training, and other services supporting the acquisition of a state integrated facility license. The Company anticipates the value of the purchase order and Strategic Cooperation Agreement will be approximately $600,000. READ MORE |
TREEZ POWERS HALL OF FLOWERS SANTA ROSA DISPENSARY FOR THE FOURTH CONSECUTIVE YEAR
SAN FRANCISCO, May 01, 2023 — Treez, the leading enterprise commerce technology platform that streamlines retail operations within the cannabis industry, announces it will continue to be the Hall of Flowers Santa Rosa exclusive point-of-sale software provider for the fourth consecutive year!
Hall of Flowers will take place in Santa Rosa, California from May 3rd through 4th, 2023. This year, Hall of Flowers Santa Rosa will combine both of their previous California shows, Palm Springs and Santa Rosa into one big event, featuring innovative new products alongside technology, speaker sessions, and educational activations. The one-of-a-kind show centers the weed industry with several unique consumption lounges where retail buyers can interact with cannabis brands’ products on-site. Hall of Flowers Santa Rosa is the original show that started it all and their largest show to date.
The Hall of Flowers dispensary is operated by the acclaimed retailer NUG, which is powered by Treez, to ensure flawless transactions during California’s premier cannabis event. Hundreds of cannabis brands utilize the NUG Hall of Flowers dispensary to sell and distribute products to attendees for a nominal fee. In 2022, Treez processed nearly 6,000 transactions and 41,500 products across the two Hall of Flowers California shows. With thousands of attendees flocking to the Hall of Flowers dispensary, Treez was able to lower the average transaction time to 90 seconds during both shows. 25% of all transactions combined between both shows in 2022 were paid using a debit card processed by TreezPay, the first fully-integrated cannabis payment processing solution to offer three cashless payment options for retail dispensaries. Treez projects an increase in debit transactions in 2023 as cashless payments continue to rise.
READ MORE |
U.S. PATENT FILED BY BYND CANNASOFT TO EXPAND ITS ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING ALGORITHM TO A MALE TREATMENT DEVICE
BYND Cannasoft Subsidiary Zigi Carmel Initiatives & Investments LTD. filed U.S. Provisional Patent Application 63461609 on April 25, 2023 covering the mechanical structure, operation, and controlling aspects of a treatment device monitored by sensors and capable of stimulating the male sexual organs based on user preferences
ASHKELON, Israel and VANCOUVER, British Columbia, April 27, 2023 — BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) announced today that its Zigi Carmel Initiatives & Investments LTD. subsidiary filed U.S. Provisional Patent Application 63461609 on April 25, 2023, covering the mechanical structure, operation, and controlling aspects of a male treatment device for external use capable of gathering information and creating custom programs according to the collected data from the sensors and uploading the data to the cloud. This U.S. Provisional Patent Application marks BYND Cannasoft’s third potential candidate that could introduce new advanced haptic experiences to the fast-growing sexual wellness and sextech market.
The male treatment device utilizes artificial intelligence and machine learning algorithms to control its operational parameters based on the user’s physiological parameters. The user, or a partner, can control the device with a smartphone app. Data collected by the device’s sensors can be uploaded to the cloud where it will be stored to remember user preferences to create a custom experience for the user.
READ MORE |
LEEF BRANDS REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS ALONG WITH FIRST QUARTER 2023 FINANCIAL RESULTS
-Q1 2023 Revenue of $9.7M, up 114% from Q4 2022
-Q1 2023 Adjusted EBITDA of $726K, up 175% from Q4 2022
-Positive cashflow from operations
VANCOUVER, British Columbia, May 02, 2023 (GLOBE NEWSWIRE) — LEEF Brands, Inc. (CSE: LEEF, OTC: LEEEF) (“LEEF” or the “Company”), a leading cannabis brand operator, announced today the release of its audited financial statements for the year ended 2022 along with the unaudited first quarter of 2023.
First Quarter 2023 Highlights
Net Sales of $9.7M increased 114% from Q4 2022 and 31% from Q1 2022
Gross Profit of $3.5M increased 96% from Q4 2022 and 15% from Q1 2022
Gross Margin of 36% increased 1% from 2022 average
Adjusted EBITDA of $726K
Full Year 2022 Highlights
Net Sales of $27M, a decrease of 19% from full year 2021
Gross Profit of $9.6M, an increase of 14% from full year 2021
Gross Margin of 35%, an increase of 10% from full year 2021
Adjusted EBITDA of $($2.7M)
READ MORE |
ROSE LIFESCIENCE ADDS HEXO’S QUÉBEC PORTFOLIO FOR COMMERCIALIZATION AND DISTRIBUTION SERVICES
HUNTINGDON, Quebec, May 02, 2023 — ROSE LifeScience Inc. (“ROSE”), a Québec-based cannabis producer, distributor, and marketer, today announced that it will add HEXO Corp.’s (“HEXO”) Québec portfolio to ROSE’s industry leading commercialization and distribution services business.
Headquartered in Gatineau, Québec, HEXO delivers premium cannabis experiences that inspire customer loyalty, from recreational to therapeutic products. HEXO’s products balance THC with CBD, terpene levels and flavonoids, to create high-quality, clean, consistent customer favourites. HEXO’s state-of-the-art facilities in Masson-Angers, Québec are purpose-built and engineered to provide exceptional capacity and streamlined operations, developing innovative products to serve the cannabis market in Québec, across Canada and globally.
ROSE’s commercialization and distribution expertise will help to position HEXO’s Québec portfolio for further expansion in the province, complementing ROSE’s relationship with Tilray Brands, Inc. (“Tilray”), a long-standing ROSE commercialization and distribution partner.
READ MORE |
BELOW ARE THE LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND
DISPENSARIES IN THE STATE OF FLORIDA |
QUALIFIED PATIENTS OVER 812,000 AND 564 DISPENSING LOCATIONS |
LATEST OMMU REPORTS FROM OFFICE OF MEDICAL MARIJUANA USE IN THE STATE OF FLORIDA Highlights from
APRIL 28, 2023 Report BY THE NUMBERS Qualified Patients: (Active ID Card): APR 28 2023- 812,944 APR 21 2023- 810,675
APR 14 2023- 807,438 APR 07 2023- 805,491 MAR 31 2023- 804,066
MAR 24 2023- 802,251
Patients Last Week: 2,269 Qualified Ordering Physicians: 2,458 New Doctors Last Week: - 20 Reporting Period: APR 21 - APR 27 2023
Amount of Medical Marijuana Dispensed - (mgs THC) 293,061,077 Amount of Low-THC Cannabis Dispensed - (mgs CBD) 3,105,891 Amount of Marijuana in a From for Smoking (oz) 94,099.974 Approved Dispensing Locations: 564 ADD LAST WEEK +1
CURALEAF - WEST PALM BEACH |
UPCOMING MEETING AND CONFERENCES |
THE FLORIDA MEDICAL CANNABIS PHYSICIANS GROUP ANNUAL IN-PERSON MEETING WILL BE HELD
AT THE FLORIDA MEDICAL CANNABIS CONFERENCE & EXHIBITION SEE INFORMATION BELOW FOR REGISTRATION |
ADVERTISEMENT OPPORTUNITIES
If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.
Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:
· MMTC PROMOS LISTED IN EACH E-NEWSLETTER
• Directory Listing
• Banner Ads
• Ad Space in the Newspaper
• Feature Articles
• Weekly Newsletters
For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com
|
|
|